How can PET imaging detect early-stage cancers?

• A. By identifying structural changes in tissues
• B. By detecting metabolic changes associated with tumor growth
• C. By visualizing blood flow to organs
• D. By measuring the size of tumors

Answer: (B)

PET imaging detects early-stage cancers by sensing changes in cellular metabolism rather than just anatomy. Cancer cells often show increased glucose metabolism, a phenomenon known as high glycolytic activity, which FDG—the common PET tracer—binds to and highlights as areas of higher uptake. This metabolic signal can appear before tumors become large enough to cause visible structural changes on CT or MRI, allowing detection of cancers at an earlier stage.

Structural changes on CT reflect anatomy and size, which may not be present or are too subtle in early disease. Visualizing blood flow or perfusion requires different tracers and focuses on vascular dynamics rather than overall metabolic activity. Measuring tumor size relies on anatomical imaging and may miss small or metabolically active lesions. By combining metabolic information with precise anatomical localization in PET/CT, early cancers are identified based on their altered metabolism, making this the strongest mechanism among the options.